GROSSMAN, Tamar R.,MCCALEB, Michael L.,WATT, Andrew T.,FREIER, Susan M.
申请号:
ES14844168
公开号:
ES2745758T3
申请日:
2014.09.12
申请国别(地区):
ES
年份:
2020
代理人:
摘要:
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.